NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.64
-1.67 (-10.91%)
At close: Jul 29, 2026, 4:00 PM EDT
13.91
+0.27 (1.98%)
After-hours: Jul 29, 2026, 7:49 PM EDT
NeuroPace Employees
NeuroPace had 220 employees as of March 31, 2026. The number of employees increased by 11 or 5.26% since the number was last reported on December 31, 2025.
Employees
220
Change
11
Growth
5.26%
Revenue / Employee
$452,409
Profits / Employee
-$98,023
Market Cap
465.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 220 | 11 | 5.26% |
| Dec 31, 2025 | 209 | 25 | 13.59% |
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,450 |
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,387 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 678 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| CeriBell | 327 |
NPCE News
- 16 hours ago - NeuroPace: FDA seeks additional clinical evidence from NAUTILUS trial - TheFly
- 1 day ago - NeuroPace Transcript: FDA announcement - Transcripts
- 1 day ago - NeuroPace Press release: FDA announcement - Filings
- 1 day ago - NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy - Business Wire
- 6 days ago - NeuroPace initiated with an Outperform at Mizuho - TheFly
- 7 weeks ago - NeuroPace Transcript: AGM 2026 - Transcripts
- 2 months ago - NeuroPace announces FDA approval of ECoG Assistant - TheFly
- 2 months ago - NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting - Business Wire